Turkish pediatric cardiac surgeons choose valves by balancing durability against the child's growth. Mechanical valves offer long-term structure but require blood thinners. Bioprosthetic options avoid medication but often fail quickly in children. Surgeons like Dr. Sertac Cicek at Liv Hospital Vadistanbul prioritize anatomy and lifestyle when selecting the optimal prosthesis.
- Somatic growth: Children outgrow fixed valves, making future replacement surgery inevitable as they age.
- Anticoagulation needs: Mechanical valves require lifelong Warfarin, while bioprosthetic tissue valves do not.
- Anatomical constraints: If the heart ring is too small, surgeons may use supra-annular placement.
- Device durability: Tissue valves calcify rapidly in young patients, leading to earlier structural failure.
Bookimed Expert Insight: Data shows Turkish professors often hold triple fellowships from top U.S. institutions. For example, Dr. Sertac Cicek trained at the Mayo Clinic and Texas Heart Institute. This international background allows them to perform complex hybrid procedures. They can adapt adult-sized valves for small children using specialized stitching techniques to delay repeat operations.
Patient Consensus: Families note that managing blood thinners is a major daily stressor after mechanical valve surgery. Many were surprised to learn that tissue valves are not always easier because they degrade so fast. They feel reassured when surgeons frame the procedure as a lifetime management plan rather than a single fix.
